10-K.Info (Beta Test)
Courtesy of Short Sands, LLC
10-K.Info (Beta Test)
Courtesy of Short Sands, LLC

ELEVANCE HEALTH, INC.

Ticker: ELV   Fiscal Year: 2019

Consolidated Statements of Cash Flows

Period Ending Dec 31, 2019 10-K (Filed: Feb 19, 2020)

(In Millions, except shares in actual)
 12 Months Ended12 Months Ended12 Months Ended
 Dec 31, 2019Dec 31, 2018Dec 31, 2017
Operating activities
Net income
$
4,807
3,7503,843
Adjustments to reconcile net income to net cash provided by operating activities:
Net realized (gains) losses on financial instruments(114)180(145)
Other-than-temporary impairment losses recognized in income472633
Loss on extinguishment of debt211282
Loss on disposal of assets31315
Deferred income taxes8191(1,272)
Amortization, net of accretion9861,008780
Depreciation expense147124111
Share-based compensation294226170
Changes in operating assets and liabilities:
Receivables, net(1,053)(695)(22)
Other invested assets(48)(1)(36)
Other assets(170)(26)(629)
Policy liabilities1,826(1,059)732
Unearned income115(36)(120)
Accounts payable and accrued expenses(593)122922
Other liabilities148(25)(120)
Income taxes(325)323(194)
Other, net(92)(205)(165)
Net cash provided by operating activities6,0613,8274,185
 
Investing activities
Purchases of fixed maturity securities(10,487)(8,244)(9,795)
Proceeds from fixed maturity securities:
Sales5,9146,4427,932
Maturities, calls and redemptions2,4371,9381,848
Purchases of equity securities(11,825)(896)(5,416)
Proceeds from sales of equity securities12,3642,8093,463
Purchases of other invested assets(642)(531)(1,164)
Proceeds from sales of other invested assets320411219
Changes in collateral and settlement of non-hedging derivatives0065
Changes in securities lending collateral254(149)625
Purchases of subsidiaries, net of cash acquired0(1,760)(2,080)
Purchases of property and equipment(1,077)(1,208)(791)
Other, net(50)(71)12
Net cash used in investing activities(2,792)(1,259)(5,082)
 
Financing activities
Net (repayments of) proceeds from commercial paper borrowings(297)(107)175
Proceeds from long-term borrowings2,4738355,458
Repayments of long-term borrowings(1,123)(1,684)(2,815)
Proceeds from short-term borrowings7,5909,1205,835
Repayments of short-term borrowings(8,035)(9,250)(5,000)
Changes in securities lending payable(254)150(625)
Changes in bank overdrafts(169)(210)71
Premiums paid on equity call options(1)0
Proceeds from sale of put options011
Proceeds from issuance of common stock under Equity Units stock purchase agreements01,2500
Repurchase and retirement of common stock(1,701)(1,685)(1,998)
Change in collateral and settlements of debt-related derivatives(34)23(149)
Cash dividends(818)(776)(705)
Proceeds from issuance of common stock under employee stock plans187173225
Taxes paid through withholding of common stock under employee stock plans(84)(81)(46)
Net cash (used in) provided by financing activities(2,266)(2,241)427
 
Effect of foreign exchange rates on cash and cash equivalents0(2)4
Change in cash and cash equivalents1,003325(466)
 
Cash and cash equivalents at beginning of year3,9343,609
Cash and cash equivalents at end of year4,9373,9343,609
 
External Links 
ELEVANCE HEALTH, INC. (ELV) Fiscal Year 2019
Statements of 10-K in Excel https://www.sec.gov/.../Financial.xlxs
Complete 10-K in HTML https://www.sec.gov/.../10-K.html
Complete 10-K in XBRL https://www.sec.gov/.../10-K-xbrl.zip